Skip to main content

GX CG7 (Atovaquone and Proguanil Hydrochloride 62.5 mg / 25 mg)

Pill with imprint GX CG7 is Pink, Round and has been identified as Atovaquone and Proguanil Hydrochloride 62.5 mg / 25 mg. It is supplied by Glenmark Generics Inc., USA.

Atovaquone/proguanil is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial combinations. Risk cannot be ruled out during pregnancy. Atovaquone/proguanil 62.5 mg / 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GX CG7

Atovaquone and Proguanil Hydrochloride

Imprint
GX CG7
Strength
62.5 mg / 25 mg
Color
Pink
Shape
Round
Availability
Prescription only
Drug Class
Antimalarial combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Generics Inc., USA
Inactive Ingredients
low substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, poloxamer 188, povidone k30, sodium starch glycolate type A potato, hypromelloses, polyethylene glycol 400, polyethylene glycol 8000, ferric oxide red, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68462-0563 (Discontinued) Glenmark Pharmaceuticals Inc.
00173-0676 GlaxoSmithKline

Get help with Imprint Code FAQs.

Related images for "GX CG7"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.